Research Article

Hepato-Pulmonary syndrome and Porto-Pulmonary Hypertension: Rare combination cause of Hypoxemia in patient with end-stage renal failure on Hemodialysis and hepatitis C Induced Decompensated Cirrhosis

Awad Magbri*, Mariam El-Magbri and Eussera El-Magbri

Published: 12/18/2017 | Volume 1 - Issue 1 | Pages: 008-012

Case Report

The case is that of 83 year-old African American man with hypertension, hepatitis C induced decompensated cirrhosis with ascites, end-stage renal disease (ESRD) on hemodialysis, fluid overload with peripheral edema and chronic hypotension. The patient was referred to the dialysis access center of Pittsburgh, PA for evaluation of his prolonged bleeding from the left upper arm brachial-basilic arterial-venous fistula (BBAVF).

On examination, he was found to be severely hypoxic with oxygen saturation of 80-92 mm Hg. Chest was clear on auscultation. Abdominal examination showed hepatosplenomegaly with ascites. Extremities showed 3+ peripheral edema bilaterally. His chest x-ray showed cardiomegaly with clear lung fields. His laboratory workup showed, WBC of 3.4, RBC 3.69, MCH 31.2, MCHC 32, and platelets 104 K/L. Chemistry showed Na 134, Cl 99, CO2 24, Total protein 7.2 with albumin of 2.9. SGOT was high at 44, vitamin D 42. Laboratory data were also indicative of chronic liver disease with bilirubin of 2.8, INR of 1.2, and albumin of 2.9, and platelet count of 104. Immunology for Hepatitis B Ag was negative, Hepatitis B Ab was 22 H, Hepatitis C Ab was positive. Arterial blood gas analysis showed PaO2 of 54 mmHg while breathing room air.

Read Full Article HTML DOI: 10.29328/journal.avm.1001002 Cite this Article


  1. Pham DM, Subramanian R, Parekh S. Coexisting hepatopulmonary syndrome and portopulmonary hypertension. J Clin Gastroenterol. 2010; 44: 135-140. Ref.:
  2. Toya S, Schraufnagel DE. Hepatopulomonary syndrome and pulmonary hypertension in the same patient: a pathophysiological paradox and therapeutic dilemma. Respiratory Medicine Extra. 2006; 2: 23-26. Ref.:
  3. Feltracco P, Serra E, Brezzi M, Milevoj M, Rizzi S, et al. Hemodynamic profile of portopulmonary hypertension. Transplant Proceedings. 2009; 41: 1235-1239. Ref.:
  4. Whyre MK, Hughes JM, Peters AM, Ussov W, ShetalPatel, et al. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol. 1998; 29: 85-93. Ref.:
  5. Badesch DB, Champion HC, Sanchez MA, Hoeperet MM, Loyd JE, et al. Dignosis and assessment of pulmonary arterial hypertension. J AM Coll Cardiol. 2009; 54: S55-S66. Ref.:
  6. Pabst S, Hammerstringl C, Hundt F, Gerhardt T, Grohé C, et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One. 2012; 7: 35310. Ref.:
  7. Yigla M, Fruchter O, Aharonson D, Noa Y, Shimon A.Reisner, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009; 75: 969-975. Ref.:
  8. Ramasubbu K, Deswal A, Herejurgen C, Aguilar D, Frost AE. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med. 2010; 3: 279-286. Ref.:
  9. Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, et al. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant proc. 2009; 41: 2753-2756. Ref.:
  10. Etemadi J, Zolfaghari H, Firoozi R, Ardalan MR, Toufan M, et al. Unexplained pulmonary hypertension in peritoneal dialysis and hemodialysis patients. Rev Rort Pneumol. 2012; 18: 10-14. Ref.:
  11. Fabbian F, Cantelli S, Molino C, Pala M, Longhini C, et al. Pulmonary hypertension in dialysis patients: a crosssectional Italian study. Int J Nephrol. 2010; 11: 463-475. Ref.:
  12. Zlotnick DM, Axelrod DA, Chobanian MC, Scott Friedman, Brown J, et al. Noninvasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transplant. 2010; 25: 3090-3096. Ref.:
  13. Kumbar L, Fein PA, Rafiq MA, Borawski C, Chattopadhyay J, et al. Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial. 2007; 23: 127-131. Ref.:
  14. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial transplant. 2012; 27: 3908-3914. Ref.:
  15. Kiykim AA, Horoz M, Ozcan T, Yildiz I, sari S, et al. Pulmonar hypertension in hemodialysis patients without arteriovenouws fistula: the effect of dialyzer composition. Ren Fail. 2010; 32: 1148-1152. Ref.:
  16. Evans AM, Hardie DG, Peers C, Mahmoud A. Hypoxic pulmonary vasoconstriction: mechanism of oxygen-sensing. Curr Opin Anaesthesiol. 2011; 24: 13-20. Ref.:
  17. Sakao S, Tatsumi K, Voelkel NF. Reversible of irreversible remodeling in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2010; 43: 629-634. Ref.:
  18. Halpern SC, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest. 2009; 136: 37-43. Ref.:
  19. Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008; 86: 1384-1388. Ref.:
  20. Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008; 28: 990-997. Ref.:
  21. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest. 2003; 123: 1577-1582. Ref.:
  22. Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007; 74: 503-510. Ref.:
  23. Abassi Z, Nakhoul F, Khankin E, Reisner SA, Yigla M. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula : pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens. 2006; 15: 353-360. Ref.:
  24. Sakaguchi Y, Shoji T, Kawabata H, Niihata K, Suzuki A, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol. 2011; 6: 995-1000. Ref.:
  25. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J AM Soc Nephrol. 2002; 3: 729-733. Ref.:
  26. Sica AL, Greenberg HE, Ruggiero DA, Scharf SM. Chronic intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol. 2000; 121: 173-184. Ref.:
  27. Barcelo A, de la Pena M, Ayllon O, Vega-Agapito MV, Piérola J, et al. Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea. Respiration. 2009; 77: 85-90. Ref.:
  28. Grassi G, Seravalle G, Ghiadoni L, Giovanni T, Rosa MB, et al. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6: 2620-2627. Ref.:
  29. Mallamaci F, Tripepi G, Maas R, Malatino L, Boger R, et al. Analysis of the relationship between norepinephrine and asymmetric dimethylarginine levels among patients with end-stage renal disease. J Am Soc Nephrol. 2004; 15: 435-441. Ref.:
  30. Tripepi G, Mattace Raso F, Sijbrands E, Mohamed SS, Renke Maas, et al. Inflammation and asymmetric dimethyl arginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol. 2011; 6: 1714-1721. Ref.:
  31. Yigla M, Abassi Z, Reisner SA, Nakhoul F. Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial. 2006; 19: 353-357. Ref.:
  32. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest. 1998; 114: 208-212. Ref.:
  33. Macedo IG, Lopes EP. Hepatopulmonary syndrome. San Paulo Medical Journal. 2009; 127: 223-230. Ref.:
  34. Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right to left shunting in end stage liver disease. Am J Cardiol. 1992; 70: 516-519. Ref.:
  35. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004; 363: 1461-1468. Ref.:
  36. Austin MJ, Mcougall NI, Wendon J, Elizabeth S, Knisely AS, et al. Safety and efficacy of combined use of sildenafil, bosentan and IIoprost before and after liver transplantation in severe portopulmonary hypertension. 2008; 14: 287-291. Ref.: